Medicina de Família
A variante Delta causa mais de 90% dos novos casos de Covid no Reino Unido.
15 Jun, 2021 | 11:29hDelta variant causes more than 90% of new Covid cases in UK – The Guardian
Comentário no Twitter (fio – clique para saber mais)
⚠️90-96% of all #COVID19 in 🇬🇧 caused by #DeltaVariant.🧵
📍32% of all Delta cases visiting the hospital emergency room are at least 1 dose vaccinated
📍33% who are then hospitalized vaccinated
📍45% of all deaths got at least 1 shot—➡️ 29% got 2 shots.https://t.co/RViq5NiioQ pic.twitter.com/v2OYV2GM09
— Eric Feigl-Ding (@DrEricDing) June 14, 2021
Uma nova variante do coronavírus (Delta) está em ascensão. Estes são os motivos das preocupações dos especialistas.
15 Jun, 2021 | 11:28hA new coronavirus variant is on the rise. Here’s why experts are concerned – CNN
Médicos da China afirmam que a variante Delta produz doença mais grave.
15 Jun, 2021 | 11:26hIn China’s latest outbreak, doctors say the infected get sicker, faster. – The New York Times (alguns artigos gratuitos por mês)
M-A | Ibuprofeno e outros anti-inflamatórios não hormonais (AINH) são superiores a codeína no manejo da dor pós-cirúrgica de paciente ambulatorial.
15 Jun, 2021 | 11:16hComunicado de imprensa: Ibuprofen and other NSAIDs superior to codeine for managing outpatient postoperative pain – Canadian Medical Association Journal
M-A | Em pacientes com insuficiência renal dialítica, os antagonistas dos receptores de mineralocorticoide reduzem a mortalidade por causa cardiovascular e por todas as causas sem aumentar o risco de hiperpotassemia.
15 Jun, 2021 | 11:15hEfficacy and Safety of Mineralocorticoid Receptor Antagonists in Kidney Failure Patients Treated with Dialysis: A Systematic Review and Meta-Analysis – Clinical Journal of the American Society of Nephrology (link para o resumo – $ para o texto completo)
Comentário no Twitter
Patients with kidney failure have a high risk of cardiovascular diseases. This meta-analysis suggests that mineralocorticoid receptor antagonists might improve clinical outcomes of patients with kidney failure without a major increase in hyperkalemia risk https://t.co/o3aO3KK2S6 pic.twitter.com/5xuCgs6FbQ
— CJASN (@CJASN) June 14, 2021
Educação dos pais e desigualdades na mortalidade infantil: revisão sistemática global e metanálise.
15 Jun, 2021 | 11:13hComentários: Children of well-educated people have higher survival rates – Norwegian University of Science and Technology E Parental education’s role in child survival – The Lancet
Comentário no Twitter (fio – clique para saber mais)
NEW study suggests lower parental education is a risk factor for child mortality, even after controlling for other markers of family socioeconomic status.
Thus, universal quality education could help ⬇️ neonatal & child mortality (#SDG target 3.2). Read https://t.co/1saJ9KwUyC. pic.twitter.com/5pctnQft4M
— The Lancet (@TheLancet) June 12, 2021
Podcast | Domine a angina estável com os CardioNerds.
15 Jun, 2021 | 11:12h#279 Dominate Stable Angina with the CardioNerds – The Curbsiders
Ponto de vista | Vigilância ativa como opção de tratamento para carcinoma basocelular de baixo risco.
15 Jun, 2021 | 11:11hPesquisa em laboratório mostra que o soro de pessoas plenamente vacinadas (após 2 doses) com a vacina da Pfizer–BioNTech pode neutralizar efetivamente a variante B.1.617 (Delta) e outras do SARS-CoV-2.
14 Jun, 2021 | 11:24hBNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants – Nature
Comentário no Twitter
An in-vitro study of sera from persons fully vaccinated with the Pfizer-BioNTech vaccine found that all samples neutralized SARS-CoV-2 virus variants B.1.617.1 (Kappa), B.1.617.2 (Delta), B.1.618 and B.1.525. https://t.co/7lXCVe7sPY
— Carlos del Rio (@CarlosdelRio7) June 12, 2021
O impacto da vacinação sobre as novas infecções por SARS-CoV-2 no Reino Unido – “Não há evidência de diferença entre as vacinas BNT162b2 (Pfizer-BioNTech) e ChAdOx1 (AstraZeneca).”
14 Jun, 2021 | 11:23hImpact of vaccination on new SARS-CoV-2 infections in the United Kingdom – Nature Medicine
Comentários no Twitter
The ChAdOx1 nCoV-19 and BNT162b2 #COVID19 #vaccines reduce incidence of new #SARSCoV2 infections by up to 65% with a single dose and up to 80% after two doses in the United Kingdom @kb_pouwels @ONS @Oxford_NDPH @UniofOxford https://t.co/K1f68MMYyO
— Nature Medicine (@NatureMedicine) June 9, 2021
First-dose vaccination with the Oxford–AstraZeneca or Pfizer–BioNTech vaccine against SARS-CoV-2 reduced the incidence of new infections in the UK by 61% and 66%, respectively, according to a study in @NatureMedicine. https://t.co/2TUFE1DeII pic.twitter.com/KuMtc1cD7l
— Nature Portfolio (@NaturePortfolio) June 9, 2021